Novo Nordisk Surges to 82nd in Trading Volume with $921 Million Turnover Despite Stock Price Decline

On June 25, 2025, Novo Nordisk (NVO) experienced a significant increase in trading volume, with a turnover of $921 million, marking a 76.79% rise from the previous day. This surge placed NVO at the 82nd position in terms of trading volume for the day. However, despite the high trading volume, the stock price of NVO declined by 4.78%.

Novo Nordisk's stock price has been volatile, with a 52-week range of $57.00 to $148.15. The company's market capitalization stands at $313.18 billion, with 3.39 billion shares outstanding and a public float of 3.37 billion shares. The stock has a beta of 0.60, indicating lower volatility compared to the broader market.

Novo Nordisk's earnings per share (EPS) for the trailing twelve months (TTM) is $3.40, with a price-to-earnings (PE) ratio of 21.59. The company's dividend rate for the TTM is $1.66, resulting in a yield of 2.38%. The stock's short interest is not available at this time.